Cargando…
Estimating the COVID-19 cash crunch: Global evidence and policy()
In this paper, we investigate how the COVID-19 health crisis could affect the liquidity of listed firms across 26 countries. We stress-test three liquidity ratios for each firm with full and partial operating flexibility in two simulated distress scenarios corresponding to drops in sales of 50% and...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194614/ http://dx.doi.org/10.1016/j.jaccpubpol.2020.106741 |
_version_ | 1783528374285631488 |
---|---|
author | De Vito, Antonio Gómez, Juan-Pedro |
author_facet | De Vito, Antonio Gómez, Juan-Pedro |
author_sort | De Vito, Antonio |
collection | PubMed |
description | In this paper, we investigate how the COVID-19 health crisis could affect the liquidity of listed firms across 26 countries. We stress-test three liquidity ratios for each firm with full and partial operating flexibility in two simulated distress scenarios corresponding to drops in sales of 50% and 75%, respectively. In the most adverse scenario, the average firm with partial operating flexibility would exhaust its cash holdings in about two years. At that point, its current liabilities would increase, on average, by eight times, suggesting that the average firm would have to resort to the debt market to prevent a liquidity crunch. Moreover, about 1/10th of all sample firms would become illiquid within six months. Finally, we study two different fiscal policies, tax deferrals and bridge loans, that governments could implement to mitigate the liquidity risk. Our analysis suggests bridge loans are more cost-effective to prevent a massive cash crunch. |
format | Online Article Text |
id | pubmed-7194614 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Author(s). Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71946142020-05-02 Estimating the COVID-19 cash crunch: Global evidence and policy() De Vito, Antonio Gómez, Juan-Pedro Journal of Accounting and Public Policy Article In this paper, we investigate how the COVID-19 health crisis could affect the liquidity of listed firms across 26 countries. We stress-test three liquidity ratios for each firm with full and partial operating flexibility in two simulated distress scenarios corresponding to drops in sales of 50% and 75%, respectively. In the most adverse scenario, the average firm with partial operating flexibility would exhaust its cash holdings in about two years. At that point, its current liabilities would increase, on average, by eight times, suggesting that the average firm would have to resort to the debt market to prevent a liquidity crunch. Moreover, about 1/10th of all sample firms would become illiquid within six months. Finally, we study two different fiscal policies, tax deferrals and bridge loans, that governments could implement to mitigate the liquidity risk. Our analysis suggests bridge loans are more cost-effective to prevent a massive cash crunch. The Author(s). Published by Elsevier Inc. 2020 2020-04-25 /pmc/articles/PMC7194614/ http://dx.doi.org/10.1016/j.jaccpubpol.2020.106741 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article De Vito, Antonio Gómez, Juan-Pedro Estimating the COVID-19 cash crunch: Global evidence and policy() |
title | Estimating the COVID-19 cash crunch: Global evidence and policy() |
title_full | Estimating the COVID-19 cash crunch: Global evidence and policy() |
title_fullStr | Estimating the COVID-19 cash crunch: Global evidence and policy() |
title_full_unstemmed | Estimating the COVID-19 cash crunch: Global evidence and policy() |
title_short | Estimating the COVID-19 cash crunch: Global evidence and policy() |
title_sort | estimating the covid-19 cash crunch: global evidence and policy() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194614/ http://dx.doi.org/10.1016/j.jaccpubpol.2020.106741 |
work_keys_str_mv | AT devitoantonio estimatingthecovid19cashcrunchglobalevidenceandpolicy AT gomezjuanpedro estimatingthecovid19cashcrunchglobalevidenceandpolicy |